Advertisement

Topics

Daiichi settles undisclosed drug side-effects case for $300 million

04:24 EDT 2 Aug 2017 | Pharmafile

Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with a $300 million pay-out for those patients who had complications using the drug. The company did not admit any wrongdoing on its part, claiming that the litigation was “without merit” and that it “does not admit liability”.

read more

Original Article: Daiichi settles undisclosed drug side-effects case for $300 million

NEXT ARTICLE

More From BioPortfolio on "Daiichi settles undisclosed drug side-effects case for $300 million"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...